Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tejaswini Dhawale, M.D.

Concepts (66)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematologic Neoplasms5202418960.660 Why?
Lymphoma, Extranodal NK-T-Cell12017480.550 Why?
Terminal Care2202417600.490 Why?
Uncertainty120177540.390 Why?
Lymphoma, Non-Hodgkin3202413740.340 Why?
Quality of Life82024133610.300 Why?
Telemedicine1202430510.280 Why?
Neoplasms32024221640.260 Why?
Hematopoietic Stem Cell Transplantation3202156700.260 Why?
Physician-Patient Relations1201732490.220 Why?
Immunotherapy, Adoptive3202414690.200 Why?
Lung Neoplasms12024133370.170 Why?
Adaptation, Psychological3202426320.150 Why?
Anxiety5202445720.150 Why?
Lymphocyte Depletion120196020.140 Why?
Leukemia, Myeloid, Acute2202236130.130 Why?
Empathy120214730.130 Why?
Perception1202211970.130 Why?
Antigens, CD19120194250.130 Why?
International Classification of Diseases120219090.130 Why?
Neurotoxicity Syndromes120193000.120 Why?
Prognosis52024296200.120 Why?
Patient Acceptance of Health Care2202432040.110 Why?
Depression4202481220.090 Why?
Social Support1202121720.090 Why?
Receptors, Antigen, T-Cell1201925490.080 Why?
Communication1202438710.080 Why?
Palliative Care1202436000.080 Why?
Graft vs Host Disease1202130300.080 Why?
Cross-Sectional Studies32024261120.070 Why?
T-Lymphocytes12024101940.070 Why?
Humans1620247614230.060 Why?
Immunotherapy1201946500.050 Why?
Electronics120213170.040 Why?
Aged, 80 and over12024589560.040 Why?
Physicians1201745910.040 Why?
Middle Aged520242208260.040 Why?
Retrospective Studies22024805820.040 Why?
Antineoplastic Combined Chemotherapy Protocols12019117400.040 Why?
Vidarabine120193360.040 Why?
Longitudinal Studies22024145990.040 Why?
Death120216760.030 Why?
Male520243607360.030 Why?
Aged220241692350.030 Why?
Checklist120218280.030 Why?
Cyclophosphamide1201922180.030 Why?
Female420243925810.030 Why?
Caregivers1202422370.020 Why?
Regression Analysis1202163430.020 Why?
Pilot Projects1202486330.020 Why?
Disease Management1201925070.020 Why?
Massachusetts1202188320.020 Why?
Socioeconomic Factors1202178250.020 Why?
Combined Modality Therapy1201985290.020 Why?
Clinical Trials as Topic1202280000.020 Why?
Databases, Factual1202179560.020 Why?
Adult320242211480.020 Why?
Neoplasm Recurrence, Local1202392770.020 Why?
Survival Rate12019127200.010 Why?
Delivery of Health Care1202153350.010 Why?
Stress Disorders, Post-Traumatic1202145790.010 Why?
Algorithms12021140260.010 Why?
Follow-Up Studies12019391170.010 Why?
Adolescent12024883130.010 Why?
Treatment Outcome12021646510.010 Why?
Animals120191684410.000 Why?
Dhawale's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.